Comprehensive Update on Urothelial Carcinoma of the Bladder: Clinical Presentation, Diagnosis, Staging, and Evidence-Based Management for Clinicians

Epidemiology and Pathobiology Urothelial carcinoma (UC), formerly termed transitional cell carcinoma (TCC), accounts for >90% of primary bladder malignancies and remains the fifth most common cancer in the United States…

Continue ReadingComprehensive Update on Urothelial Carcinoma of the Bladder: Clinical Presentation, Diagnosis, Staging, and Evidence-Based Management for Clinicians

Comprehensive Review of Small Cell Lung Carcinoma (SCLC): Pathophysiology, Diagnosis, and Management – A Clinician’s Guide with Evidence-Based Insights

Updated with Current Evidence-Based Guidelines (2023–2024) Epidemiology and Pathobiological Context Small cell lung carcinoma (SCLC) accounts for approximately 13–15% of all primary lung cancers, with an incidence declining modestly over…

Continue ReadingComprehensive Review of Small Cell Lung Carcinoma (SCLC): Pathophysiology, Diagnosis, and Management – A Clinician’s Guide with Evidence-Based Insights